Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/16831

Title: Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies
Authors: Stolzing, Alexandra
Jones, E.
McGonagle, D.
Scutt, Andrew
Keywords: Aging
Heat shock proteins
Human mesenchymal stem cells
Oxidative damage
Senescence
Issue Date: 2008
Publisher: © Elsevier Ireland Ltd
Citation: STOLZING, A. ... et al, 2008. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mechanisms of Ageing and Development, 129 (3), pp. 163 - 173.
Abstract: Human mesenchymal stem cells (hMSC) represent a promising cell-based therapy for a number of degenerative conditions. Understanding the effect of aging on hMSCs is crucial for autologous therapy development in older subject whom degenerative diseases typically afflict. Previous investigations into the effects of aging on hMSC have proved contradictory due to the relative narrow age ranges of subjects assessed and the exclusive reliance of in vitro assays. This study seeks to address this controversy by using a wider range of donor ages and by measuring indices of cellular aging as well as hMSC numbers ex vivo and proliferation rates. CFU-f analysis and flow cytometry analysis using a CD45 low/D7fib +ve/LNGF +ve gating strategy were employed. In addition a variety of markers of cellular aging, oxidative damage and senescence measured. A reduction in CFU-f and CD45 low/D7fib +ve/LNGF +ve cell numbers were noted in adulthood relative to childhood. Indices of aging including oxidative damage, ROS levels and p21 and p53 all increased suggesting a loss of MSC fitness with age. These data suggest that hMSC numbers obtained by marrow aspiration decline with age. Furthermore, there is an age-related decline in overall BM MSC "fitness" which might lead to problems when using autologous aged MSC for cell-based therapies. © 2007 Elsevier Ireland Ltd. All rights reserved.
Description: This article is closed access.
Version: Published
DOI: 10.1016/j.mad.2007.12.002
URI: https://dspace.lboro.ac.uk/2134/16831
Publisher Link: http://dx.doi.org/10.1016/j.mad.2007.12.002
ISSN: 0047-6374
Appears in Collections:Closed Access (Mechanical, Electrical and Manufacturing Engineering)

Files associated with this item:

File Description SizeFormat
23 Human MSC aging.pdfPublished version1.01 MBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.